Vivek Subbiah

140PUBLICATIONS

509CO-AUTHORS

Predictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (140)

Sort by Publication Date:

|Jun 01, 2026

Tumor-Agnostic Therapies: Translating Scientific Breakthroughs Into Global Implementation.

|May 27, 2026

Should We Call Every Cancer a Rare Cancer?

|Apr 03, 2026

Living Guidelines for Tumor-Agnostic Therapies: A Pathway to Next-Generation Cancer Treatment.

Vivek Subbiah, Thomas K Oliver, Jim Palma

|Mar 26, 2026

Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced <i>RET</i> Fusion-Positive Non-Small Cell Lung Cancer.

Benjamin Besse, Vivek Subbiah, Giuseppe Curigliano

|Mar 02, 2026

From Information Overload to Patient-Centered Oncology Care Through Apomediation.

Zouina Sarfraz, Vivek Subbiah, Manmeet S Ahluwalia

|Feb 26, 2026

Molecular-Guided Precision Oncology in Cancer of Unknown Primary: A State-of-the-Art Perspective.

Vivek Subbiah, Elie Rassy, Frank A Greco

Pageof 24

Frequent Collaborators

15 joint publications

Aung Naing

14 joint publications

Jason Roszik

14 joint publications

David S Hong

13 joint publications

Razelle Kurzrock

11 joint publications

Siqing Fu

10 joint publications

Funda Meric-Bernstam

Mohamed Gouda

Giuseppe Curigliano

Jacob J Adashek

Janku Filip

Frequent Collaborators

15 joint publications

Aung Naing

14 joint publications

Jason Roszik

14 joint publications

David S Hong

13 joint publications

Razelle Kurzrock